IL155608A0 - Human cord blood derived unrestricted somatic stem cells (ussc) - Google Patents

Human cord blood derived unrestricted somatic stem cells (ussc)

Info

Publication number
IL155608A0
IL155608A0 IL15560801A IL15560801A IL155608A0 IL 155608 A0 IL155608 A0 IL 155608A0 IL 15560801 A IL15560801 A IL 15560801A IL 15560801 A IL15560801 A IL 15560801A IL 155608 A0 IL155608 A0 IL 155608A0
Authority
IL
Israel
Prior art keywords
stem cells
well
cord blood
somatic stem
human cord
Prior art date
Application number
IL15560801A
Other languages
English (en)
Original Assignee
Kourion Therapeutics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kourion Therapeutics Gmbh filed Critical Kourion Therapeutics Gmbh
Publication of IL155608A0 publication Critical patent/IL155608A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
IL15560801A 2000-11-03 2001-11-03 Human cord blood derived unrestricted somatic stem cells (ussc) IL155608A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24516800P 2000-11-03 2000-11-03
PCT/EP2001/012768 WO2002036751A2 (en) 2000-11-03 2001-11-03 Human cord blood derived unrestricted somatic stem cells (ussc)

Publications (1)

Publication Number Publication Date
IL155608A0 true IL155608A0 (en) 2003-11-23

Family

ID=22925565

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15560801A IL155608A0 (en) 2000-11-03 2001-11-03 Human cord blood derived unrestricted somatic stem cells (ussc)
IL155608A IL155608A (en) 2000-11-03 2003-04-28 Somatic stem cells derived from the blood of a drug of human origin in the manufacture of a drug

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL155608A IL155608A (en) 2000-11-03 2003-04-28 Somatic stem cells derived from the blood of a drug of human origin in the manufacture of a drug

Country Status (24)

Country Link
US (3) US7560280B2 (de)
EP (1) EP1404815B1 (de)
JP (2) JP4799804B2 (de)
CN (1) CN100480375C (de)
AT (1) ATE340255T1 (de)
AU (2) AU2953302A (de)
BG (1) BG107770A (de)
CA (1) CA2426987C (de)
CY (1) CY1106287T1 (de)
CZ (1) CZ20031165A3 (de)
DE (1) DE60123293T2 (de)
DK (1) DK1404815T3 (de)
EA (1) EA008619B1 (de)
EE (1) EE200300205A (de)
ES (1) ES2272563T3 (de)
HU (1) HUP0301600A3 (de)
IL (2) IL155608A0 (de)
MX (1) MXPA03003844A (de)
NO (1) NO20031999L (de)
PL (1) PL362293A1 (de)
PT (1) PT1404815E (de)
SK (1) SK5242003A3 (de)
UA (1) UA81390C2 (de)
WO (1) WO2002036751A2 (de)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU766826B2 (en) * 1998-07-30 2003-10-23 Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The Thymosin beta4 promotes wound repair
US10638734B2 (en) 2004-01-05 2020-05-05 Abt Holding Company Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
WO2002064748A2 (en) * 2001-02-14 2002-08-22 Furcht Leo T Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
US8075881B2 (en) 1999-08-05 2011-12-13 Regents Of The University Of Minnesota Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
WO2001011011A2 (en) * 1999-08-05 2001-02-15 Mcl Llc Multipotent adult stem cells and methods for isolation
US8609412B2 (en) * 1999-08-05 2013-12-17 Regents Of The University Of Minnesota Mapc generation of lung tissue
US8252280B1 (en) 1999-08-05 2012-08-28 Regents Of The University Of Minnesota MAPC generation of muscle
US7927587B2 (en) * 1999-08-05 2011-04-19 Regents Of The University Of Minnesota MAPC administration for the treatment of lysosomal storage disorders
US7015037B1 (en) * 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
WO2003020215A2 (en) * 2001-08-29 2003-03-13 Regenerx Biopharmaceuticals, Inc. Methods of treating mycocardial event related coditions with thymosin beta 4
DE10144326B4 (de) * 2001-09-10 2005-09-22 Siemens Ag Verfahren und System zur Überwachung eines Reifenluftdrucks
DE10158680B4 (de) * 2001-11-30 2004-04-08 Universitätsklinikum Hamburg-Eppendorf Verfahren zur ex vivo-Expansion und -Differenzierung von multipotenten Stammzellen
AU2003216111C1 (en) * 2002-01-23 2008-08-21 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Pure populations of astrocyte restricted precursor cells and methods for isolation and use thereof
ES2287447T3 (es) * 2002-02-19 2007-12-16 Medipost, Co., Ltd. Metodos de aislamiento y expansion del cultivo de celulas troncales/madre mesenquimatosas a partir de sangre del cordon umbilical, y metodo de diferenciacion de celulas troncales/madre mesenquimatosas derivadas de sangre del cordon umbilical en diversos tejidos mesenquimatosos.
AU2003298775B2 (en) 2002-11-26 2008-07-17 Anthrogenesis Corporation Cytotherapeutics, cytotherapeutic units and methods for treatments using them
US20060228798A1 (en) 2002-11-27 2006-10-12 Catherine Verfaillie Homologous recombination in multipotent adult progenitor cells
US7470538B2 (en) * 2002-12-05 2008-12-30 Case Western Reserve University Cell-based therapies for ischemia
US20040258670A1 (en) * 2002-12-05 2004-12-23 Case Western Reserve University Cell-based therapies for ischemia
JP3762975B2 (ja) * 2003-03-18 2006-04-05 学校法人慶應義塾 単球由来多能性細胞ｍｏｍｃ
US20040203142A1 (en) * 2003-04-14 2004-10-14 Reliance Life Sciences Pvt. Ltd. Growth of neural precursor cells using umbilical cord blood serum and a process for the preparation thereof for therapeutic purposes
WO2005001080A2 (en) 2003-06-27 2005-01-06 Ethicon, Incorporated Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
CA2529718C (en) 2003-06-27 2012-10-23 Universite Laval Method of isolating cells from umbilical cord
US20070077237A1 (en) * 2003-10-09 2007-04-05 Udi Damari Method for freezing, thawing and transplantation of viable cartilage
EP1694345A1 (de) 2003-12-04 2006-08-30 Regents Of The University Of Minnesota Zusammensetzungen und verfahren zur behandlung von lysosomalen speicherkrankheiten
GB0329449D0 (en) * 2003-12-19 2004-01-28 Omnicyte Ltd Stem cells
EP1544290A1 (de) * 2003-12-19 2005-06-22 Yu-Show Fu System zur Herstellung somatischer Zellen
JP2007520462A (ja) * 2003-12-19 2007-07-26 バイアセル インコーポレーティッド ヒト臍帯血由来多能性細胞の疾患の処置のための使用方法
WO2005072790A1 (en) * 2004-02-02 2005-08-11 I.M.T. Interface Multigrad Technology Ltd. Device for directional cooling of biological matter
EP1711053A2 (de) * 2004-02-02 2006-10-18 I.M.T. Interface Multigrad Technology Ltd. Biologisches material sowie verfahren und lösungen für seine konservierung
CA2556018A1 (en) 2004-02-11 2005-09-09 Aldagen, Inc. Stem cell populations and methods of use
US7670596B2 (en) 2004-04-23 2010-03-02 Bioe, Inc. Multi-lineage progenitor cells
US7622108B2 (en) 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
US20070298015A1 (en) * 2004-04-28 2007-12-27 Viacell, Inc. Treatment of Muscular Dystrophy with Mobilized Peripheral Blood Pluripotent Cells
JP2007536936A (ja) 2004-05-14 2007-12-20 ベクトン・ディキンソン・アンド・カンパニー 幹細胞集団および使用方法
US7892726B2 (en) * 2004-06-07 2011-02-22 Core Dynamics Limited Method for sterilizing lyophilized eukaryotic anuclear cells with gamma irradiation
US8037696B2 (en) * 2004-08-12 2011-10-18 Core Dynamics Limited Method and apparatus for freezing or thawing of a biological material
CA2593549C (en) 2005-01-07 2016-04-26 Wake Forest University Health Sciences Regeneration of pancreatic islets by amniotic fluid stem cell therapy
EP1859028B1 (de) * 2005-02-10 2015-12-02 Regents Of The University Of Minnesota Vaskuläre Endothelzellen
WO2006090372A2 (en) * 2005-02-22 2006-08-31 I.M.T. Interface Multigrad Technology Ltd. Preserved viable cartilage, method for its preservation, and system and devices used therefor
CN101575590B (zh) * 2005-02-28 2012-05-23 中国医学科学院血液学研究所泰达生命科学技术研究中心 人脐带间充质干细胞的制备方法
WO2006113881A2 (en) * 2005-04-19 2006-10-26 The Johns Hopkins University Method of using stroma cells from cord blood to expand and engraft nucleated cells from cord blood
WO2006121428A1 (en) * 2005-05-05 2006-11-16 Regents Of The University Of Minnesota Use of nk cell inhibition to facilitate persistence of engrafted mhc- i negative cells
CA2607218C (en) * 2005-05-05 2016-08-23 Regents Of The University Of Minnesota Use of mapc or progeny therefrom to populate lymphohematopoietic tissues
EP1888741B1 (de) * 2005-05-27 2013-04-17 Viacell, Inc. Behandlung von ischämie mit stammzellen
WO2007117262A2 (en) * 2005-07-29 2007-10-18 Athersys, Inc. Culture of non-embryonic cells at high cell density
US8198085B2 (en) * 2005-08-03 2012-06-12 Core Dynamics Limited Somatic cells for use in cell therapy
DE602005017812D1 (de) * 2005-08-26 2009-12-31 Seoul Nat Univ Ind Foundation Multipotente blutstammzellen aus der nabelschnur und zellbehandlungsmittel damit zur behandlung der ischämischen krankheit
CN101310012B (zh) 2005-10-14 2012-05-09 明尼苏达大学董事会 非胚胎干细胞分化成具有胰腺表型的细胞
WO2007070870A1 (en) 2005-12-16 2007-06-21 Ethicon, Inc. Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
PT2471904T (pt) 2005-12-29 2019-02-25 Celularity Inc População de células estaminais placentárias
CA2646491A1 (en) * 2006-04-17 2007-10-25 Bioe, Inc. Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
US7875453B2 (en) * 2006-06-14 2011-01-25 Bioe Llc Differentiation of multi-lineage progenitor cells to hepatocytes
PL2089511T3 (pl) 2006-11-13 2015-02-27 Depuy Synthes Products Llc Rozrost in vitro komórek pochodzących z tkanki pępowinowej wykorzystujących mikronośniki
WO2008085229A2 (en) * 2006-11-15 2008-07-17 Arteriocyte Inc. Cell-based therapies for treating liver disease
WO2008063675A2 (en) * 2006-11-24 2008-05-29 Regents Of The University Of Minnesota Endodermal progenitor cells
CN101541954B (zh) 2006-11-30 2012-12-26 Medipost株式会社 含有人脐带血衍生的间充质干细胞的组合物诱导神经前体细胞或神经干细胞分化和增殖为神经细胞的用途
CA2693827A1 (en) * 2007-07-25 2009-01-29 Bioe, Inc. Differentiation of multi-lineage progenitor cells to chondrocytes
EP2212418A4 (de) * 2007-10-31 2010-12-08 Cryo Cell Int Verfahren zur co-kultivierung von zellen aus nabelschnurblut und menstruellen stammzellen
WO2009085216A2 (en) 2007-12-20 2009-07-09 Squicor Compositions and methods for detecting or elimninating senescent cells to diagnose or treat disease
AU2009205886B2 (en) * 2008-01-18 2015-08-27 Katholieke Universiteit Leuven Stem cell aggregates and methods for making and using
US20090202978A1 (en) * 2008-02-13 2009-08-13 Ginadi Shaham Method and apparatus for freezing of a biological material
US20090233993A1 (en) * 2008-03-06 2009-09-17 Burnham Institute For Medical Research Compositions and methods for inhibiting gsk3 activity and uses thereof
CN101543644B (zh) * 2008-03-27 2012-07-25 中国人民解放军总医院 无支架工程软骨组织的构建方法及其产品
CA2724839A1 (en) * 2008-05-21 2009-11-26 Bioe Llc Differentiation of multi-lineage progenitor cells to pancreatic cells
CA2734446C (en) 2008-08-22 2017-06-20 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
EP2331566B1 (de) 2008-08-26 2015-10-07 City of Hope Verfahren und zusammensetzungen zur verstärkung der anti-tumor-effektor-funktion von t-zellen
GB0818725D0 (en) 2008-10-13 2008-11-19 Habib Nagy A Pharmaceutical composition
EP2182055A1 (de) 2008-10-14 2010-05-05 Heinrich-Heine-Universität Düsseldorf Aus der menschlichen Nabelschnur gewonnene unrestringierte somatische Stammzellen (USSC)
WO2010049752A1 (en) 2008-10-31 2010-05-06 Katholieke Universiteit Leuven Optimized methods for differentiation of cells into cells with hepatocyte and hepatocyte progenitor phenotypes, cells produced by the methods, and methods for using the cells
KR20100054711A (ko) 2008-11-14 2010-05-25 메디포스트(주) 간엽 줄기세포 또는 이의 배양액을 포함하는 신경질환의 예방 또는 치료용 조성물
US10179900B2 (en) 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
WO2011011500A1 (en) 2009-07-21 2011-01-27 Abt Holding Company Use of stem cells to reduce leukocyte extravasation
WO2011011477A1 (en) 2009-07-21 2011-01-27 Abt Holding Company Use of stem cells to reduce leukocyte extravasation
US8759098B2 (en) 2009-12-04 2014-06-24 Boston Biomedical Research Institute, Inc. Method for cloning pluripotent stem cells
US9081008B2 (en) 2009-12-04 2015-07-14 James Sherley Detecting and counting tissue—specific stem cells and uses thereof
WO2011106476A1 (en) * 2010-02-25 2011-09-01 Abt Holding Company Modulation of microglia activation
DK2539436T3 (da) 2010-02-25 2021-10-18 Abt Holding Co Modulering af makrofagaktivering
US20110206647A1 (en) * 2010-02-25 2011-08-25 Abt Holding Company Modulation of Angiogenesis
MX2012011543A (es) 2010-04-08 2013-05-06 Anthrogenesis Corp Tratamiento de sarcoidosis empleando celulas madre placentarias.
SG185526A1 (en) 2010-05-12 2012-12-28 Abt Holding Co Modulation of splenocytes in cell therapy
WO2011158125A2 (en) 2010-06-17 2011-12-22 Katholieke Universiteit Leuven Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells
CA2838330C (en) 2010-08-23 2021-01-26 President And Fellows Of Harvard College Optogenetic probes for measuring membrane potential
EP2609191B1 (de) 2010-08-24 2017-11-22 Regents Of The University Of Minnesota Nichtstatische suspensionskultur aus zellverbänden
WO2012048276A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
US8969315B2 (en) 2010-12-31 2015-03-03 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
US20120258439A1 (en) * 2011-04-11 2012-10-11 Ali Bin M Abdullah Jaffar Protein-Free Culture Media Products
CN102776150A (zh) * 2011-05-13 2012-11-14 上海交通大学医学院附属第九人民医院 一种诱导脐带间充质干细胞分化为内皮细胞的方法
JP6104896B2 (ja) 2011-06-01 2017-03-29 アントフロゲネシス コーポレーション 胎盤幹細胞を使用する疼痛の治療
PL2718416T3 (pl) 2011-06-06 2020-05-18 ReGenesys BVBA Namnażanie komórek macierzystych w bioreaktorach włóknisto-kapilarnych
GB201119335D0 (en) 2011-11-09 2011-12-21 Univ Leuven Kath Hepatitis virus infectable stem cells
IL289870B2 (en) 2013-04-12 2023-03-01 Lafrancesca Saverio Improving organs for transplantation
AU2014266935B2 (en) 2013-04-30 2020-06-11 Katholieke Universiteit Leuven Cell therapy for myelodysplastic syndromes
WO2015073913A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
EP2952578A1 (de) 2014-06-03 2015-12-09 Peter Wernet Epigenetische Reprogrammierung von fötalen Stammzellen
BR112017005631A2 (pt) 2014-09-19 2018-06-26 City Of Hope células t com receptor de antígeno coestimulador quimérico direcionadas à il13ra2
TW201613622A (en) * 2014-10-14 2016-04-16 Bionet Corp Composition for skincare and pharmaceutical composition and preparation method thereof
NZ745530A (en) 2016-01-21 2023-03-31 Abt Holding Co Stem cells for wound healing
CN106377547B (zh) * 2016-09-30 2019-05-31 孔五一 脐带血再生粒子的提取方法及其用途
AU2021267900A1 (en) 2020-05-08 2023-01-19 Gallant Pet Inc. Uterine-derived regenerative cell compositions and uses thereof
CN113637633B (zh) * 2021-08-16 2023-11-03 浙江大学 一种促进间充质干细胞向成骨细胞分化的方法
EP4405375A1 (de) 2021-09-23 2024-07-31 President and Fellows of Harvard College Genetisch codierte spannungsindikatoren und verwendungen davon

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3639949A1 (de) * 1986-11-22 1988-06-09 Diagen Inst Molekularbio Verfahren zur trennung von langkettigen nukleinsaeuren
US5192553A (en) * 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5851832A (en) * 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
US5672346A (en) * 1992-07-27 1997-09-30 Indiana University Foundation Human stem cell compositions and methods
US6482231B1 (en) * 1995-11-20 2002-11-19 Giovanni Abatangelo Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
US5842477A (en) * 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
AU2730497A (en) * 1996-04-17 1997-11-07 Case Western Reserve University Cryopreservation and extensive subculturing of human mesenchymal stem cells
US5843633A (en) * 1996-04-26 1998-12-01 Amcell Corporation Characterization of a human hematopoietic progenitor cell antigen
JPH10295369A (ja) 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
JPH10306027A (ja) 1997-03-07 1998-11-17 Otsuka Pharmaceut Co Ltd 免疫寛容誘導剤
US6387369B1 (en) * 1997-07-14 2002-05-14 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
DE19833476B4 (de) 1998-07-24 2005-08-25 Huss, Ralf, Dr. Genetisch modifizierte CD34-Negative, adhärent wachsende hämatopoetische Stammzellen und deren Verwendung in der Gentherapie
JP2003521474A (ja) 1999-04-27 2003-07-15 レイトン バイオサイエンス インコーポレイテッド 慢性発作のための細胞療法
US20020142457A1 (en) * 1999-12-28 2002-10-03 Akihiro Umezawa Cell having the potentiality of differentiation into cardiomyocytes
ES2287447T3 (es) * 2002-02-19 2007-12-16 Medipost, Co., Ltd. Metodos de aislamiento y expansion del cultivo de celulas troncales/madre mesenquimatosas a partir de sangre del cordon umbilical, y metodo de diferenciacion de celulas troncales/madre mesenquimatosas derivadas de sangre del cordon umbilical en diversos tejidos mesenquimatosos.
US20040197310A1 (en) * 2003-02-12 2004-10-07 Sanberg Paul R. Compositions and methods for using umbilical cord progenitor cells in the treatment of myocardial infarction

Also Published As

Publication number Publication date
ATE340255T1 (de) 2006-10-15
CY1106287T1 (el) 2011-10-12
JP4799804B2 (ja) 2011-10-26
AU2953302A (en) 2002-05-15
HUP0301600A2 (hu) 2003-10-28
EA008619B1 (ru) 2007-06-29
EP1404815A2 (de) 2004-04-07
BG107770A (bg) 2004-02-27
US20020164794A1 (en) 2002-11-07
JP2004521617A (ja) 2004-07-22
US20090238803A1 (en) 2009-09-24
PL362293A1 (en) 2004-10-18
CA2426987C (en) 2013-06-11
NO20031999D0 (no) 2003-05-02
CZ20031165A3 (cs) 2003-10-15
MXPA03003844A (es) 2004-10-15
HUP0301600A3 (en) 2005-12-28
CA2426987A1 (en) 2002-05-10
WO2002036751A3 (en) 2004-01-08
ES2272563T3 (es) 2007-05-01
DE60123293T2 (de) 2007-05-10
EA200300536A1 (ru) 2003-12-25
HK1071771A1 (zh) 2005-07-29
DE60123293D1 (de) 2006-11-02
US7556801B2 (en) 2009-07-07
PT1404815E (pt) 2006-12-29
CN1553951A (zh) 2004-12-08
CN100480375C (zh) 2009-04-22
US20050142118A1 (en) 2005-06-30
EP1404815B1 (de) 2006-09-20
JP4805960B2 (ja) 2011-11-02
IL155608A (en) 2009-08-03
WO2002036751A2 (en) 2002-05-10
JP2008179642A (ja) 2008-08-07
UA81390C2 (en) 2008-01-10
NO20031999L (no) 2003-07-02
EE200300205A (xx) 2003-08-15
US7560280B2 (en) 2009-07-14
DK1404815T3 (da) 2007-01-08
AU2002229533B2 (en) 2007-07-26
SK5242003A3 (en) 2003-11-04

Similar Documents

Publication Publication Date Title
AU2953302A (en) Human cord blood derived unrestricted somatic stem cells (ussc)
EP1077254A3 (de) Potential zur Differenzierung in multiple Mesodermalzellinien für von Adiposegewebe stammenden Stromazellen und deren Verwendungen
WO2001068811A3 (de) Verfahren zur in vitro-herstellung von dreidimensionalem, vitalem knorpel- oder knochengewebe und dessen verwendung als transplantationsmaterial
GEP20022804B (en) Erythropoietin Derivatives
EA200600076A1 (ru) Композиции и способы увеличения активности теломеразы
GB0001309D0 (en) Valve arrangement
WO2003040346A3 (en) Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
WO2005038012A3 (en) Cartilage and bone repair and regeneration using postpartum-derived cells
IL153288A0 (en) Use of growth hormone or a derivative thereof in the preparation of a medicament for hematopoiesis
DK1405906T3 (da) Schwann-celler stammende fra stromale knoglemarvsceller
SG11201900986YA (en) Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells
DE60313356D1 (de) Verwendungvon dextransulfat zur behandlung von ibmir
IL158216A0 (en) Disposable vaginal cannula for the simultaneous administration of drugs in different forms
MD2355F1 (en) Method of preimplanting preparation
CN205964440U (zh) 一种康复科专用骨科护理装置
CN106563160A (zh) 制备组织工程骨的方法
MD1135G2 (ro) Metodă de tratament al afecţiunilor parodonţiului
Guan et al. Stem cell use in musculoskeletal disorders
Zou Tissue Engineering for Degenerative Intervertebral Discs
Peng et al. Influence of various volume fractions of platelet-rich plasma on the proliferation of rat hair follicle stem cells
Hwang Hematopoietic Stem Cell Expansion
MD1137F1 (en) Method for treatment of woman sterility
Rosocha et al. Slovakia: Five years experience of multitissue bank with the production of allografts and cultured living cells
Xiao et al. Craniofacial Defects and their Regeneration: Destruction and Regeneration of the Periodontium, Craniofacial Tumors, Trauma, and Congenital Defects
Ritter Bone repair